Charles River Laboratories International (CRL) News Today $150.20 -0.80 (-0.53%) As of 11:35 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period SG Americas Securities LLC Increases Stake in Charles River Laboratories International, Inc. (NYSE:CRL)SG Americas Securities LLC grew its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 16,153.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 267,202 sharesJune 10 at 8:12 AM | marketbeat.comPolen U.S SMID Company Growth Strategy Sold Charles River Laboratories International (CRL) for More Attractive OpportunitiesJune 9 at 2:57 PM | msn.comRhumbline Advisers Buys 3,405 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Rhumbline Advisers lifted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 86,730 shares of the medical research company'sJune 9 at 4:08 AM | marketbeat.comReinhart Partners LLC. Decreases Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Reinhart Partners LLC. lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 3.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 48,742 shares of the medical research compaJune 7, 2025 | marketbeat.comEquities Analysts Set Expectations for CRL FY2026 EarningsJune 6, 2025 | americanbankingnews.comResearch Analysts Set Expectations for CRL Q2 EarningsJune 6, 2025 | americanbankingnews.comZacks Research Has Negative Outlook for CRL FY2026 EarningsCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Analysts at Zacks Research lowered their FY2026 earnings per share (EPS) estimates for shares of Charles River Laboratories International in a note issued to investors on Monday, June 2nd. Zacks Research analyst R. DepartmeJune 5, 2025 | marketbeat.comGAMMA Investing LLC Grows Position in Charles River Laboratories International, Inc. (NYSE:CRL)GAMMA Investing LLC raised its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 24,226.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 210,427 shares oJune 5, 2025 | marketbeat.comZacks Research Has Strong Estimate for CRL Q2 EarningsCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Zacks Research boosted their Q2 2025 EPS estimates for Charles River Laboratories International in a report released on Monday, June 2nd. Zacks Research analyst R. Department now anticipates that the medical research companJune 4, 2025 | marketbeat.comFragasso Financial Advisors Inc Sells 9,597 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Fragasso Financial Advisors Inc trimmed its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 66.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,941 sharesJune 3, 2025 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Shares Unloaded Rep. Robert Bresnahan, Jr.Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Charles River Laboratories International, Inc. (NYSE:CRL). In a filing disclosed on May 31st, the Representative disclosed that they had sold between $1,001 and $15,000 in Charles River Laboratories International stock onJune 3, 2025 | marketbeat.comZacks Research Brokers Raise Earnings Estimates for CRLJune 3, 2025 | americanbankingnews.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $3.58 Million in Charles River Laboratories International, Inc. (NYSE:CRL)Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 19,410 shares of the meJune 2, 2025 | marketbeat.comWhat is Zacks Research's Estimate for CRL Q2 Earnings?Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Investment analysts at Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for Charles River Laboratories International in a note issued to investors on Wednesday, May 28th. Zacks Research analyst R. DJune 2, 2025 | marketbeat.comVersant Capital Management Inc Purchases 2,172 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Versant Capital Management Inc lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1,324.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,336 sharJune 1, 2025 | marketbeat.comCalifornia State Teachers Retirement System Has $14.04 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)California State Teachers Retirement System lessened its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 76,035 shJune 1, 2025 | marketbeat.comToronto Dominion Bank Sells 8,281 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Toronto Dominion Bank decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 32.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 17,336 shares of the medical research company's stock after selling 8,2June 1, 2025 | marketbeat.comZacks Research Has Negative Forecast for CRL Q3 EarningsJune 1, 2025 | americanbankingnews.comZacks Research Issues Negative Forecast for CRL EarningsCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Research analysts at Zacks Research dropped their Q3 2025 earnings per share (EPS) estimates for Charles River Laboratories International in a report issued on Wednesday, May 28th. Zacks Research analyst R. Department now aMay 31, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Confluence Investment Management LLCConfluence Investment Management LLC lifted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 3.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 96,526 shares of the medical researMay 30, 2025 | marketbeat.comCharles River Laboratories International, Inc. (CRL): A Bull Case TheoryMay 30, 2025 | insidermonkey.comCharles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease ResearchMay 29, 2025 | finance.yahoo.comCharles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease ResearchMay 29, 2025 | finance.yahoo.comCharles River Laboratories International Q1 Earnings TranscriptMay 28, 2025 | marketbeat.comJefferies Financial Group Inc. Purchases 12,353 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Jefferies Financial Group Inc. increased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 226.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 17,802 shares of the medical research company's stock after buying an aMay 28, 2025 | marketbeat.comDo Wall Street Analysts Like Charles River Laboratories Stock?May 27, 2025 | msn.comKayne Anderson Rudnick Investment Management LLC Lowers Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Kayne Anderson Rudnick Investment Management LLC cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 6.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The instituMay 27, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 46,994 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 18.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutiMay 27, 2025 | marketbeat.comTwo Sigma Advisers LP Buys 11,800 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Two Sigma Advisers LP boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 72.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 28,100 shares of the medical researchMay 27, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Mackenzie Financial CorpMackenzie Financial Corp boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 0.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 977,073 shares of tMay 26, 2025 | marketbeat.comNeo Ivy Capital Management Has $361,000 Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Neo Ivy Capital Management cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 60.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,956 shares of the medical research compaMay 26, 2025 | marketbeat.comRoyal Bank of Canada Has $28.63 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Royal Bank of Canada cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 7.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 155,104 shares of the mediMay 26, 2025 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Upgraded at Redburn AtlanticRedburn Atlantic raised Charles River Laboratories International from a "neutral" rating to a "buy" rating and dropped their price objective for the company from $188.00 to $182.00 in a report on Friday.May 25, 2025 | marketbeat.comTwo Sigma Investments LP Buys 59,610 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Two Sigma Investments LP grew its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 309.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 78,861 shares of the mMay 25, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Toronto Dominion BankToronto Dominion Bank lessened its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 32.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 17,336 shares of the medical research company's stock aMay 25, 2025 | marketbeat.comRedburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PTMay 24, 2025 | insidermonkey.comVoloridge Investment Management LLC Has $28.90 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Voloridge Investment Management LLC increased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 107.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 156,574 shares of the medical research company's stock after puMay 24, 2025 | marketbeat.comRedburn Atlantic Upgrades Charles River Laboratories International (CRL)May 24, 2025 | msn.comRedburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PTMay 24, 2025 | msn.comCharles River Laboratories International, Inc. (CRL) Extends CEO's Employment AgreementMay 23, 2025 | gurufocus.comWorldquant Millennium Advisors LLC Buys New Position in Charles River Laboratories International, Inc. (NYSE:CRL)Worldquant Millennium Advisors LLC bought a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1May 23, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Twinbeech Capital LPTwinbeech Capital LP increased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1,584.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 44,480 shares of the medical researcMay 22, 2025 | marketbeat.comTeza Capital Management LLC Invests $710,000 in Charles River Laboratories International, Inc. (NYSE:CRL)Teza Capital Management LLC acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 3,847 shares of the medicalMay 22, 2025 | marketbeat.comSouthpoint Capital Advisors LP Sells 69,976 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Southpoint Capital Advisors LP lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 10.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 600,000 shares of the medical research company'May 21, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Man Group plcMan Group plc boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 359.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 82,390 shares of the medicalMay 20, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Lazard Asset Management LLCLazard Asset Management LLC raised its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 42.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,757 shares of tMay 20, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of "Hold" by BrokeragesShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have earned an average recommendation of "Hold" from the seventeen brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recMay 20, 2025 | marketbeat.comQuantinno Capital Management LP Raises Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Quantinno Capital Management LP boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 78.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor ownMay 19, 2025 | marketbeat.comJanus Henderson Group PLC Boosts Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Janus Henderson Group PLC grew its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 22.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5May 19, 2025 | marketbeat.comBaird Financial Group Inc. Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL)Baird Financial Group Inc. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 67.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,592 shares of the medical research company'sMay 18, 2025 | marketbeat.com Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼0.611.01▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼1511▲CRL Articles Average Week Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Bio-Rad Laboratories News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRL Stock Free CRL Stock Alerts